Open AccessP1389: RUXOLITINIB DEMONSTRATES A GREATER CORTICOSTEROID‐SPARING EFFECT THAN BEST AVAILABLE THERAPY IN PATIENTS WITH CORTICOSTEROID‐REFRACTORY/DEPENDENT CHRONIC GRAFT‐VS‐HOST DISEASE
Author(s) -
Zeiser R.,
Russo D.,
Ram R.,
Hashmi S.,
Chakraverty R.,
Moritz Middeke J.,
Giebel S.,
Sarkar R.,
Gowda M.,
Gunes S.,
Stefanelli T.,
Lee S. J.,
Teshima T.,
Locatelli F.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000848416.66197.62
Subject(s) - medicine , refractory (planetary science) , prednisone , corticosteroid , ruxolitinib , gastroenterology , calcineurin , transplantation , bone marrow , physics , astrobiology , myelofibrosis